Literature DB >> 3967106

Malignant melanoma, evaluation of clinical follow up by questionnaire survey.

M W Regan, C D Reid, R W Griffiths, J C Briggs.   

Abstract

A retrospective questionnaire study, by post, revealed that 69% of patients, still living following first tumour recurrence, had detected the recurrence themselves prior to routine clinic appointments. Nearly 90% developed their first recurrence in the first 5 years following primary surgical treatment. Not only could the length of routine clinic follow-up after primary melanoma treatment be shortened, but with further education of the patient and involvement of the general practitioner it seems likely that patients can be trusted to detect their own recurrences and seek appropriate advice.

Entities:  

Mesh:

Year:  1985        PMID: 3967106     DOI: 10.1016/0007-1226(85)90080-3

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  5 in total

1.  Cutaneous melanomas exhibiting unusual biologic behavior.

Authors:  H M Shaw; J K Rivers; S W McCarthy; W H McCarthy
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

2.  Skin malignancy and the reconstructive plastic surgeon.

Authors:  R W Griffiths
Journal:  Ann R Coll Surg Engl       Date:  1989-05       Impact factor: 1.891

3.  Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.

Authors:  Ann Y Lee; Nicolas Droppelmann; Katherine S Panageas; Qin Zhou; Charlotte E Ariyan; Mary S Brady; Paul B Chapman; Daniel G Coit
Journal:  Ann Surg Oncol       Date:  2016-11-01       Impact factor: 5.344

Review 4.  Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Authors:  Kate D Cromwell; Merrick I Ross; Yan Xing; Jeffrey E Gershenwald; Richard E Royal; Anthony Lucci; Jeffrey E Lee; Janice N Cormier
Journal:  Melanoma Res       Date:  2012-10       Impact factor: 3.599

5.  Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.

Authors:  S Kruijff; E Bastiaannet; A J H Suurmeijer; H J Hoekstra
Journal:  Ann Surg Oncol       Date:  2010-05-05       Impact factor: 5.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.